Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and sendal virus

Advances in Enzyme Regulation

Volumn 36, Issue , 1996, Pages 325-347

  Kido, Hiroshi ^a   Niwa, Yasuharu ^a   Beppu, Yoshihito ^a   Towatari, Takae ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; CD4 ANTIGEN; GLYCOPROTEIN GP 120; MEMBRANE RECEPTOR; PEPTIDE; PROTEIN; PROTEINASE; PROTEINASE INHIBITOR; RECOMBINANT PROTEIN; SERINE PROTEINASE; SURFACTANT; TRYPTASE; TRYPTASE CLARA; TRYPTASE TL(2); VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; ANIMAL; ANTILEUKOPROTEASE; CHEMISTRY; CLARA CELL; CONFERENCE PAPER; CONFORMATIONAL TRANSITION; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOLOGY; INFLUENZA VIRUS A; LUNG; METABOLISM; MOLECULAR GENETICS; PARAMYXOVIRUS; PATHOGENICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN PROCESSING; RAT; RAT STRAIN; RECEPTOR BINDING; SENDAI VIRUS; VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; WESTERN BLOTTING;

EID: 0030445074     PISSN: 00652571     EISSN: None     Source Type: Book Series    
DOI: 10.1016/0065-2571(95)00016-X     Document Type: Conference Paper

References (43)

1. M. HOMMA and M. OHUCHI, Trypsin action on the growth of Sendai virus in tissue culture cell, J. Virol. 12, 1457-1465 (1973).
2. H.-D. KLENK and R. ROTT, The molecular biology of influenza virus pathogenicity, Advan. Virus Res. 34, 247-281 (1988).
3. R. ROTT, Molecular basis of infectivity and pathogenicity of myxovirus, Arch. Virol. 59, 285-298 (1979).
4. A. SCHEID and P. W. CHOPPIN, Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity by proteolytic cleavage of an inactive precursor protein of Sendai virus, Virology 57, 475-490 (1974).
5. P. J. MADDON, A. G. DALGLEISH and J. S. McDOUGAL, The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain, Cell 47, 333-348 (1986).
6. P. P. CLAPHAM, D. BLANC and R. A. WEISS, Specific cell-surface requirements for infection of CD4-positive cells by human immunodeficiency virus type 1, type 2 and simian immunodeficiency virus, Virology 181, 703-715 (1991).
7. T. HATTORI, A. KOITO, K. TAKATSUKI, H. KIDO and N. KATUNUMA, Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection, FEBS Lett. 248, 48-52 (1989).
8. + lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. Purification and characterization, J. Biol. Chem. 265, 21979-21985 (1990).
9. + lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp120, FEBS Lett. 286, 233-236 (1991).
10. M. TASHIRO and M. HOMMA, Pneumotropism of Sendai virus in relation to protease-mediated activation in mouse lungs, Infect. Immun. 39, 879-888 (1983).
11. H. KIDO, Y. YOKOGOSHI, K. SAKAI, M. TASHIRO, Y. KISHINO, A. FUKUTOMI and N. KATUNUMA, Isolation and characterization of a novel trypsin-like protease found in rat bronchiolar epithelial Clara cells. A possible activator of the viral fusion glycoprotein, J. Biol. Chem. 267, 13573-13579 (1992).
12. M. TASHIRO, Y. YOKOGOSHI, K. TOBITA, J. T. SETO, R. ROTT and H. KIDO, Tryptase Clara, an activating protease for Sendai virus in rat lungs, is involved in pneumopathogenicity, J. Virol. 66, 7211-7216 (1992).
13. M. A. K. MARKWELL, A new-solid-state reagent to iodinate proteins: conditions for the efficient labeling of antiserum, Anal. Biochem. 125, 427-432 (1982).
14. M. TASHIRO, M. YAMAKAWA, K. TOBITA, H.-D. KLENK, R. ROTT and J. T. SETO, Organ tropism of Sendai virus in mice: proteolytic activation of the fusion glycoprotein in mouse organs and budding site at the bronchial epithelium, J. Virol. 64, 3627-3634 (1990).
15. H. KIDO, K. SAKAI, Y. KISHINO and M. TASHIRO, Pulmonary surfactant is a potential endogenous inhibitor of proteolytic activation of Sendai virus and influenza virus, FEBS Lett. 322, 115-119 (1993).
16. K. SAKAI, Y. KAWAGUCHI, Y. KISHINO and H. KIDO, Electron immunohistochemical localization in rat bronchiolar epithelial cells of tryptase Clara, which determines the pneumotropism and pathogenicity of Sendai virus and influenza virus, J. Histochem. Cytochem. 41, 89-93 (1993).
17. K. SAKAI, T. KOHRI, M. TASHIRO, Y. KISHINO and H. KIDO, Sendai virus infection changes the subcellular localization of tryptase Clara in rat bronchiolar epithelial cells, Eur. Respir. J. 7, 686-692 (1994).
18. M. G. GRÜTTER, G. TENDRICH, R. HUBER and W. BODE, The 2.5AÅX-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analyzed in its complex with bovine α-chymotrypsin, EMBO J. 7, 345-351 (1988).
19. J.-M. SALLENAVE, A. SILVA, M. E. MARSDEN and A. P. RYLE, Secretion of mucus proteinase inhibitor and elafin by Clara cell and type II pneumocyte cell line, Am. J. Respir. Cell Mol. Biol. 8, 126-133 (1993).
20. L. N. A. WILLEMS, J. A. KRAMPS, T. STIJNEN, P. J. STERK, J. J. WEENING and J. H. DIJKMAN, Antileukoprotease-containing bronchiolar cells. Relationship with morphologic disease of small airway and parenchyma, Am. Rev. Respir. Dis. 139, 1244-1250 (1989).
21. E. FINK, E. JAUMANN, H. FRITS, H. INGRISCH and C. S. WRIGHT, Protease-inhibitor im menschlichen Spermaplasma Isolierung durch Affinitätschromatographie und Hemmverhalten, Hoppe-Seyler's Z. Physiol. Chem. 352, 1591-1594 (1971).
22. O. WALLNER and H. FRITS, Characterization of an acid-stable proteinase inhibitor in human cervical mucus, Hoppe-Seyler's Z. Physiol. Chem. 355, 709-715 (1974).
23. B. MECKELEIN, M. KEMME, T. NIKIFOROV, H. APPELHANS and H. G. GASSEN, Expression and characterization of recombinant second domain variants of human mucus proteinase inhibitor (MPI), Biomed. Biochim. Acta 50, 673-676 (1991).
24. 107) of elastase and cathepsin G activities: Consequence for neutrophil-platelet cooperation, Brit. J. Pharmacol. 108, 1100-1106 (1993).
25. R. C. THOMPSON and K. OHLSSON, Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte protease, Proc. Natl. Acad. Sci. U.S.A 83, 6692-6696 (1986).
26. U. SEEMULLER, M. ARNHOLD, H. FRITZ, K. WIEDENMANN, W. MACHLEIDT, JR., R. HEINZEL, H. APPELHANS, H. G. GASSEN and F. LOTTSPEIDT, The acid-stable proteinase inhibitor of human mucus secretions (HUSI-1, antileukoprotease), FEBS Letters 199, 43-18 (1986).
27. E. FINK, R. NETTELBECK and H. FRITZ, Inhibition of mast cell chymase by eglin c and antileukoprotease (HSUI-I), Biol. Chem. Hoppe. Seyler 367, 567-571 (1986).
28. A. G. DALGLEISH, P. C. L. BEVERLEY, P. R. CLAPHAM, D. H. CRAWFORD, M. F. GREAVES and R. A. WEISS, The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus, Nature 312, 763-767 (1984).
29. D. KLATZMANN, E. CHAMPAGNE, S. CHAMARET, J. GRUEST, D. GUETARD, T. HERCEND, J.-C GLUCKMAN and L. MONTAGNIER, T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV, Nature 312, 767-768 (1984).
30. J. P. MOORE and P. L. NARA, The role of the V3 loop in HIV infection, AIDS 5 (supplement), 521-533 (1991).
31. P. R. CLAPHAM, D. BLANC and R. A. WEISS, Specific cell surface requirements for infection of CD4-positive cells by human immunodeficiency virus type 1, type 2 and simian immunodeficiency virus, Virology 181, 703-715 (1991).
32. P. E. STEPHENS, G. CLEMENTS, G. T. YARRANTON and J. P. MOORE, A chink in HIV's armour? Nature 343, 219 (1990).
33. K. A. J. JAVAHERIAN, C. LANGLOIS, K. L. MCDANAL, L. I. ROSS, C. L. ECKLER, A. T. JELLIS, J. R. PROFY, D. P. RUSCHE, D. P. BOLOGNESI, S. D. PUTNEY and T. J. MATTHEWS, Principal neutralization domain of the human immunodeficiency virus type 1 envelope protein, Proc. Natl. Acad. Sci. U.S.A 86, 6768-6772 (1989).
34. E. O. FREED, D. J. MYERS and R. RISSER, Identification of the principal neutralizing determinant of human immuno-deficiency virus type 1 as a fusion domain, J. Virol. 65, 190-194 (1991).
35. G. J. CLEMENTS, J. M. J. PRICE-JONES, P. E. STEPHENS, C. SUTTON, T. F. SCHULTZ, P. R. CLAPHAM, J. A. McKEATING, M. O. MCCLURE, S. THOMSON, M. MARSH, J. KAY, R. A. WEISS and J. P. Moore, The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: A possible function in viral fusion? AIDS Res. Hum. Retrovir. 7, 3-16 (1991).
36. A. WERNER and J. A. LEVY, Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4, J. Virol. 67, 2566-2574 (1993).
37. D. H. SMITH, R. A. BYRN, S. A. MARSTERS, T. GREGORY, J. E. GROOPMAN and D. J. CAPON, Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen, Science 238, 1704-1707 (1987).
38. + lymphoid cells, Biochem. Biophys. Res. Commun. 201, 1390-1395 (1994).
39. B envelope glycoprotein gp120 and the surface antigen CD4: Role of carbohydrate in binding and cell fusion, Proc. Natl. Acad. Sci. U.S.A, 84, 5424-5428 (1987).
40. D. C. MONTEFIORI, W. E. ROBINSON, JR. and W. M. MITCHELL, Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1, Proc. Natl. Acad. Sci. U.S.A, 85, 9248-9252 (1988).
41. J. D. LAMAN, J. M. M. SCHELLEKENS, Y. H. ABACIOGLU, G. K. LEWIS, M. TERSMETTE, R. A. M. FOUCHIER, J. P. M. LANGEDIJK, E. CLASSEN and M. J. A. BOERSMA, Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain, J. Virol. 66, 1823-1831 (1992).
42. L.-E. AVRIL, M. D. MARTINO-FERRER, G. PIGNEDE, M. SEMAN and F. GAUTHIER, Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G, FEBS Letters 345, 81-86 (1994).
43. J. LEVY, C. CHENG-MEYER, D. DINA and P. LUCIW, AIDS retrovirus (ARV-2) clone replicates in transfected human and animal fibroblasts, Science 337, 368-370 (1986).